List of Excipients in API RALOXIFENE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RALOXIFENE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | ANHYDROUS LACTOSE | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | CARNAUBA WAX | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | CROSPOVIDONE | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | HYPROMELLOSE | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | LACTOSE MONOHYDRATE | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | MAGNESIUM STEARATE | |
| Eli Lilly and Company | EVISTA | raloxifene hydrochloride | 0002-4184 | POLYETHYLENE GLYCOL 400 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing RALOXIFENE HYDROCHLORIDE
Detailed excipient profiles for RALOXIFENE HYDROCHLORIDE
Excipient focus: ANHYDROUS LACTOSE
RALOXIFENE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
RALOXIFENE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARNAUBA WAX
RALOXIFENE HYDROCHLORIDE drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | raloxifene hydrochloride | 0002-4184 |
| Physicians Total Care Inc | raloxifene hydrochloride | 54868-4170 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RALOXIFENE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
RALOXIFENE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
RALOXIFENE HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
RALOXIFENE HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSPOVIDONE
RALOXIFENE HYDROCHLORIDE drug variants containing CROSPOVIDONE
RALOXIFENE HYDROCHLORIDE drug variants not containing CROSPOVIDONE
Excipient focus: HYDROXYPROPYL CELLULOSE
RALOXIFENE HYDROCHLORIDE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | raloxifene hydrochloride | 0440-5295 |
| Camber Pharmaceuticals Inc | raloxifene hydrochloride | 31722-256 |
| Exelan Pharmaceuticals Inc | raloxifene hydrochloride | 76282-256 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
RALOXIFENE HYDROCHLORIDE drug variants containing HYPROMELLOSE
RALOXIFENE HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
RALOXIFENE HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
RALOXIFENE HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
RALOXIFENE HYDROCHLORIDE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | raloxifene hydrochloride | 50268-694 |
| Amneal Pharmaceuticals LLC | raloxifene hydrochloride | 65162-057 |
| Cadila Pharmaceuticals Limited | raloxifene hydrochloride | 71209-082 |
| Modavar Pharmaceuticals LLC | raloxifene hydrochloride | 72241-010 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
RALOXIFENE HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
RALOXIFENE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
RALOXIFENE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
RALOXIFENE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
RALOXIFENE HYDROCHLORIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | raloxifene hydrochloride | 0440-5295 |
| Camber Pharmaceuticals Inc | raloxifene hydrochloride | 31722-256 |
| Exelan Pharmaceuticals Inc | raloxifene hydrochloride | 76282-256 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing MANNITOL
Excipient focus: POLOXAMER 407
RALOXIFENE HYDROCHLORIDE drug variants containing POLOXAMER 407
RALOXIFENE HYDROCHLORIDE drug variants not containing POLOXAMER 407
Excipient focus: POLYDEXTROSE
RALOXIFENE HYDROCHLORIDE drug variants containing POLYDEXTROSE
RALOXIFENE HYDROCHLORIDE drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
RALOXIFENE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
RALOXIFENE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
RALOXIFENE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
RALOXIFENE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
RALOXIFENE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 4000
RALOXIFENE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
RALOXIFENE HYDROCHLORIDE drug variants containing POLYSORBATE 80
RALOXIFENE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
RALOXIFENE HYDROCHLORIDE drug variants containing POVIDONE
RALOXIFENE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
RALOXIFENE HYDROCHLORIDE drug variants containing POVIDONE K30
RALOXIFENE HYDROCHLORIDE drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
RALOXIFENE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | raloxifene hydrochloride | 0002-4184 |
| Physicians Total Care Inc | raloxifene hydrochloride | 54868-4170 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
RALOXIFENE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
RALOXIFENE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
RALOXIFENE HYDROCHLORIDE drug variants containing STARCH, CORN
RALOXIFENE HYDROCHLORIDE drug variants not containing STARCH, CORN
Excipient focus: TALC
RALOXIFENE HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | raloxifene hydrochloride | 68462-393 |
| >Company | >Ingredient | >NDC |
RALOXIFENE HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
RALOXIFENE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
RALOXIFENE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
